Newsroom

Newsroom

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $950 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.

Media Contacts

Events Coverage

Bennah Serfaty
Senior Director, Communications
(212) 806-1607
bennah.serfaty@amfar.org

External Communications

Robert Kessler
Manager, Program Communications
(212) 806-1602
robert.kessler@amfar.org

2025


Progress on HIV—Derailed


Over two decades and counting, the global HIV response has saved 27 million lives, thanks in large part to its single biggest contributor: the United States. The sudden withdrawal of international assistance from the U.S. has had a catastrophic effect, particularly in low- and middle-income countries, as a new UNAIDS report titled AIDS, Crisis, and the Power to Transform details. Interrupted testing, treatment, and prevention services, as well as debilitated healthcare infrastructure, threaten to derail progress and alter the lives of millions.

Read More


Breakthroughs Amid Crisis


A glance at the program for the upcoming 13th International AIDS Society Conference on HIV Science (IAS 2025) and anyone can see that science is delivering—long-acting injectables for HIV treatment and PrEP, AI’s promise to revolutionize research and healthcare, and further progress toward a cure. Yet other sessions are trying to grapple with the thorniest of questions: How do we sustain such successes in HIV biomedical science, prevention, treatment, and care in the face of devastating funding cuts?

Read More


­Statement from amfAR on FDA Approval of Lenacapavir for HIV Pre-Exposure Prophylaxis


NEW YORK, June 18, 2025 — The U.S. Food and Drug Administration (FDA) announced Thursday that it has approved the antiretroviral drug lenacapavir for use as HIV pre-exposure prophylaxis (PrEP). Twice-annual injection of lenacapavir was shown to be 100% effective at preventing HIV transmission in one clinical trial and was named Science’s Breakthrough of the Year in 2024. 

Read More



2024


2023


2022


2021


2020


2019